JPH0367080B2 - - Google Patents
Info
- Publication number
- JPH0367080B2 JPH0367080B2 JP5834884A JP5834884A JPH0367080B2 JP H0367080 B2 JPH0367080 B2 JP H0367080B2 JP 5834884 A JP5834884 A JP 5834884A JP 5834884 A JP5834884 A JP 5834884A JP H0367080 B2 JPH0367080 B2 JP H0367080B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- aqueous solution
- separated
- organic solvent
- purification method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Steroid Compounds (AREA)
Description
【発明の詳細な説明】
本発明はウルソデオキシコール酸、ケノデオキ
シコール酸または3α−ヒドロキシ−7−ケトコ
ラン酸の精製方法に関する。さらに詳しくは、そ
れら胆汁酸中に不純物として含まれるリトコール
酸に代表されるモノヒドロキシ胆汁酸(ただし、
3α−ヒドロキシ−7−ケトコラン酸を除く。以
下同様。)およびコラン酸に代表されるヒドロキ
シ基を持たない胆汁酸(以下、ノンヒドロキシ胆
汁酸という。)等を選択的に除去する方法に関す
る。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for purifying ursodeoxycholic acid, chenodeoxycholic acid or 3α-hydroxy-7-ketocholanic acid. More specifically, the monohydroxy bile acids represented by lithocholic acid, which are contained as impurities in these bile acids (however,
Excluding 3α-hydroxy-7-ketocholanic acid. Same below. ) and bile acids without hydroxyl groups (hereinafter referred to as non-hydroxy bile acids) such as colanic acid.
ウルソデオキシコール酸およびケノデオキシコ
ール酸は胆石溶解剤、利胆剤として有用であり、
3α−ヒドロキシ−7−ケトコラン酸はこれらの
製造中間体として有用である。ウルソデオキシコ
ール酸、ケノデオキシコール酸および3α−ヒド
ロキシ−7−ケトコラン酸は、例えばコール酸
(3α、7α、12α−トリヒドロキシ−5α−コラン酸)
を出発原料として製造し、その際それぞれの製造
工程に由来する副生成物、例えばリトコール酸
(3α−ヒドロキシ−5β−コラン酸)、コラン酸、
7α(または7β)−ヒドロキシコラン酸、3α、7α−
ジヒドロキシ−12−ケトコラン酸および未反応コ
ール酸などが残存し、それらの分離精製が非常に
困難とされてきた。特にリトコール酸は好ましく
ない毒性を有しているため効率よく除去すること
が望まれている。 Ursodeoxycholic acid and chenodeoxycholic acid are useful as gallstone dissolving agents and choleretic agents.
3α-hydroxy-7-ketocholanic acid is useful as an intermediate in their production. Ursodeoxycholic acid, chenodeoxycholic acid and 3α-hydroxy-7-ketocholanic acid are, for example, cholic acid (3α, 7α, 12α-trihydroxy-5α-cholanic acid)
is produced as a starting material, and by-products derived from the respective production steps, such as lithocholic acid (3α-hydroxy-5β-cholanic acid), colanic acid,
7α (or 7β)-hydroxycholanic acid, 3α, 7α-
Dihydroxy-12-ketocholanic acid and unreacted cholic acid remain, making it extremely difficult to separate and purify them. In particular, since lithocholic acid has undesirable toxicity, it is desired to remove it efficiently.
従来公知のウルソデオキシコール酸またはケノ
デオキシコール酸の精製方法を大別するとエス
テル化またはアシル化して再結晶あるいはカラム
クロマトグラフイーをおこなう方法(特開昭52−
153954、同52−153955、同52−156851)、有機
溶剤から直接再結晶する方法(化学実験学第10
巻、495頁、1943年、特開昭52−139053、同53−
137945、同55−79398、同56−32498)、アルカ
リ金属を用いる方法(特開昭49−95955、同50−
126654)などである。しかし、これらは操作の簡
便さ、収率、精製純度などの点で必ずしも満足さ
れるものではなかつた。また、本発明者らは先に
粗製胆汁酸の精製法として、水に溶けにくい有機
溶剤とアルカリ水溶液を用いる二相抽出法による
操作方法について出願したが(特開昭58−
113202)、さらに研究を行なつた結果、モノヒド
ロキシ胆汁酸およびノンヒドロキシ胆汁酸(これ
らは環内に、二重結合を有するものも含む。)を
選択的、特異的かつ効率よく分離除去する方法を
見出だし、ここに発明を完成した。 Conventionally known methods for purifying ursodeoxycholic acid or chenodeoxycholic acid can be roughly divided into methods of esterification or acylation followed by recrystallization or column chromatography (Japanese Unexamined Patent Publication No. 1973-
153954, 52-153955, 52-156851), method of direct recrystallization from organic solvent (Chemical Experimental Science No. 10)
Volume, 495 pages, 1943, Japanese Unexamined Patent Publication No. 52-139053, 53-
137945, 55-79398, 56-32498), methods using alkali metals (JP-A-49-95955, 50-
126654) etc. However, these methods were not always satisfactory in terms of ease of operation, yield, purification purity, etc. In addition, the present inventors have previously filed an application for a two-phase extraction method using an organic solvent that is hardly soluble in water and an alkaline aqueous solution as a purification method for crude bile acids (Japanese Patent Application Laid-Open No. 1983-1998-1).
113202), and as a result of further research, we discovered a method for selectively, specifically, and efficiently separating and removing monohydroxy bile acids and non-hydroxy bile acids (including those with double bonds in the ring). He discovered this and completed his invention.
モノヒドロキシ胆汁酸してはリトコール酸、
7α−ヒドロキシコラン酸、7β−ヒドロキシコラ
ン酸、3β−ヒドロキシコラン酸等が挙げられ、
ノンヒドロキシ胆汁酸としてはコラン酸等であ
り、その他水酸基が脱離して生成する環内に二重
結合を有する胆汁酸も含む(以下、これらを不純
物胆汁酸と総称する。)。これらの不純物胆汁酸は
単独または2種以上混在していてもよい。不純物
胆汁酸のうちリトコール酸は毒性を有しており、
またケノデオキシコール酸またはウルソデオキシ
コール酸の通常の製造工程においてリトコール酸
が1%前後副生することが避け難いので、これを
0.1%以下に効率よく除く精製方法が望まれてい
る。本発明はリトコール酸をはじめ上記の不純物
胆汁酸を選択的、特異的に除去する方法を提供す
る。 Monohydroxy bile acids include lithocholic acid,
Examples include 7α-hydroxycholanic acid, 7β-hydroxycholanic acid, 3β-hydroxycholanic acid, etc.
Non-hydroxy bile acids include colanic acid and the like, and also include bile acids having a double bond in the ring produced by the elimination of a hydroxyl group (hereinafter, these are collectively referred to as impurity bile acids). These impurity bile acids may be used alone or in combination of two or more. Among impurity bile acids, lithocholic acid is toxic.
Furthermore, in the normal manufacturing process of chenodeoxycholic acid or ursodeoxycholic acid, it is unavoidable that around 1% of lithocholic acid is produced as a by-product.
A purification method that efficiently removes carbon dioxide to 0.1% or less is desired. The present invention provides a method for selectively and specifically removing the above-mentioned impurity bile acids including lithocholic acid.
次に、本発明方法を説明する。 Next, the method of the present invention will be explained.
リトコール酸、コラン酸等の不純物を含む粗製
胆汁酸を0.85〜1.1倍モル量のアルカリを含む水
溶液に懸濁または溶解し、この水溶液中へ粗製胆
汁酸に対し0.05〜5.0倍モル量の下式で示される
第3級アミン
(式中R1、R2およびR3は同一または異なつて炭
素数1〜20個のアルキル基またはアラルキル基を
示す。ただし、R1、R2、R3のうち少なくとも1
つは炭素数3以上のアルキル基またはアラルキル
基を示す。)
及び水と層分離し得る有機溶剤を加え、得られ
た混合液を5〜10分間撹拌する。液が2層に分離
するまで静置したのち水層を分取する。使用する
第3級アミンが塩を形成している場合は、さらに
中和相当量のアルカリを加える。この操作によつ
て不純物胆汁酸が有機溶媒層へ移行する。この操
作を粗製胆汁酸の純度に応じて1〜3回行う。有
機溶剤とアルカリ水溶液の量は0.8:1〜1:9
(v/v)が好ましい。 A crude bile acid containing impurities such as lithocholic acid and colanic acid is suspended or dissolved in an aqueous solution containing an alkali of 0.85 to 1.1 times the molar amount, and a molar amount of 0.05 to 5.0 times the crude bile acid is added to the aqueous solution using the following formula. Tertiary amine represented by (In the formula, R 1 , R 2 and R 3 are the same or different and represent an alkyl group or an aralkyl group having 1 to 20 carbon atoms. However, at least one of R 1 , R 2 and R 3
One represents an alkyl group or an aralkyl group having 3 or more carbon atoms. ) and an organic solvent that can be separated into layers from water are added and the resulting mixture is stirred for 5-10 minutes. After allowing the liquid to stand until it separates into two layers, separate the aqueous layer. If the tertiary amine used forms a salt, an amount of alkali equivalent to neutralization is further added. By this operation, the impurity bile acid is transferred to the organic solvent layer. This operation is carried out 1 to 3 times depending on the purity of the crude bile acid. The amount of organic solvent and alkaline aqueous solution is 0.8:1 to 1:9.
(v/v) is preferred.
また、予め粗製胆汁酸を1.0〜5.0倍モル量の第
3級アミンと共に有機溶剤に溶解し、この有機溶
剤へ0.85〜1.1倍モル量のアルカリを含有する水
溶液を加えたのち前記と同様に撹拌、静置、分
取、酸沈を行なつてもよい。 In addition, crude bile acid is dissolved in advance in an organic solvent together with 1.0 to 5.0 times the molar amount of tertiary amine, and an aqueous solution containing an alkali of 0.85 to 1.1 times the molar amount is added to this organic solvent, and then stirred in the same manner as above. , standing still, fractionation, and acid precipitation.
なお、有機溶剤層は次の方法で洗浄再生して再
使用できる。 Note that the organic solvent layer can be washed and reused by the following method.
水層を分取したのちの不純物胆汁酸および第3
級アミンを含有する有機溶媒層へ、不純物胆汁酸
に対して1〜3倍モル量のアルカリ水溶液を有機
溶媒量に対して0.2〜3.0倍量(v/v)加えて撹
拌する。この操作によつて、今度は不純物胆汁酸
がアルカリ水溶液層は移行し、有機溶媒層は不純
物胆汁酸が除去された第3級アミンのみを含有す
る溶媒系となり、これを分取すれば再度次の精製
工程に使用できるので経済的であり、かつ工業的
に大変有利である。 After separating the aqueous layer, impurity bile acids and third
An alkaline aqueous solution in an amount of 1 to 3 times the molar amount of the impurity bile acid is added to the organic solvent layer containing the class amine in an amount of 0.2 to 3.0 times the amount of the organic solvent (v/v) and stirred. By this operation, the impurity bile acid is transferred to the alkaline aqueous solution layer, and the organic solvent layer becomes a solvent system containing only the tertiary amine from which the impurity bile acid has been removed. It is economical and industrially advantageous because it can be used in the purification process.
目的胆汁酸を含有する、分取した水溶液中に微
量の有機溶媒が残存するときは必要に応じて蒸溜
により除去する。次いで、該水溶液中に希塩酸、
希硫酸等の酸を加えて酸性化すると目的胆汁酸が
沈殿する。 If a trace amount of organic solvent remains in the separated aqueous solution containing the target bile acid, it is removed by distillation as necessary. Next, dilute hydrochloric acid was added to the aqueous solution,
When acidified by adding an acid such as dilute sulfuric acid, the target bile acid precipitates.
本発明において使用されるアルカリとしては水
酸化ナトリウム、水酸化カリウム、水酸化アンモ
ニウム等の水酸化アルカリ、炭酸ナトリウム、炭
酸カリウム、炭酸アンモニウム等の炭酸アルカ
リ、モノエタノールアミン、ピペラジン、ピペリ
ジン、ピリジン等の有機塩基が挙げられる。 Examples of the alkali used in the present invention include alkali hydroxides such as sodium hydroxide, potassium hydroxide, and ammonium hydroxide, alkali carbonates such as sodium carbonate, potassium carbonate, and ammonium carbonate, monoethanolamine, piperazine, piperidine, and pyridine. Examples include organic bases.
また、第3級アミンとしては、トリプロピルア
ミン、トリブチルアミン、トリペンチルアミン、
トリヘキシルアミン、トリヘプチルアミン、トリ
オクチルアミン、トリイソオクチルアミン、トリ
−(7−メチルヘプチル)アミン、トリラウリル
アミン、トリセチルアミン、トリエイコシルアミ
ン、メチルジオクチルアミン、メチルジラウリル
アミン、メチルジステアリルアミン、エチルジス
テアリルアミン、ジメチルオクチルアミン、ジメ
チルデシルアミン、ジメチルラウリルアミン、ジ
メチルミリスチルアミン、ジメチルパルミチルア
ミン、ジメチルステアリルアミン、ジオクチルミ
リスチルアミン、N、N−ジメチルベンジルアミ
ン等である。 In addition, examples of tertiary amines include tripropylamine, tributylamine, tripentylamine,
Trihexylamine, triheptylamine, trioctylamine, triisooctylamine, tri-(7-methylheptyl)amine, trilaurylamine, tricetylamine, trieicosylamine, methyldioctylamine, methyldilaurylamine, methyl These include distearylamine, ethyldistearylamine, dimethyloctylamine, dimethyldecylamine, dimethyllaurylamine, dimethylmyristylamine, dimethylpalmitylamine, dimethylstearylamine, dioctylmyristylamine, N,N-dimethylbenzylamine, and the like.
水と層分離し得る有機溶剤としてはn−ブタノ
ール、sec−ブタノール、n−アミルアルコール、
n−ヘキサノール等のアルコール類、酢酸エチ
ル、酢酸ブチル等のエステル類、メチルイソブチ
ルケトン、ジイソブチルケトン等のケトン類、エ
チルエーテル、イソプロピルエーテル、ジブチル
エーテル、アニソール等のエーテル類、クロロホ
ルム、ジクロルエタン、四塩化炭素等のハロゲン
化炭化水素類、シクロヘキサン、ベンゼン、トル
エン等の炭化水素類の単独または混合溶媒を、使
用する第3級アミンを溶解し得る溶媒を適宜選択
して使用する。 Organic solvents that can be separated into layers from water include n-butanol, sec-butanol, n-amyl alcohol,
Alcohols such as n-hexanol, esters such as ethyl acetate and butyl acetate, ketones such as methyl isobutyl ketone and diisobutyl ketone, ethers such as ethyl ether, isopropyl ether, dibutyl ether, and anisole, chloroform, dichloroethane, and tetrachloride. A single or mixed solvent of halogenated hydrocarbons such as carbon, hydrocarbons such as cyclohexane, benzene, toluene, etc. is used by appropriately selecting a solvent capable of dissolving the tertiary amine used.
以下に本発明の精製方法を実施例をもつて説明
する。 The purification method of the present invention will be explained below using Examples.
各実施例中の不純物胆汁酸の含量はガスクロマ
トグラフイー(日立163型ガスクロマトグラフイ
ー。内部標準にコラン酸を使用。)および薄層ク
ロマトグラフイー[シリカゲル60(メルク社製)
展開溶媒は酢酸エチル:シクロヘキサン:氷酢酸
(50:13:3)]によつて測定した。 The content of impurity bile acid in each example was determined by gas chromatography (Hitachi model 163 gas chromatography. Cholanic acid was used as an internal standard) and thin layer chromatography [Silica gel 60 (Merck & Co., Ltd.)].
The developing solvent was ethyl acetate:cyclohexane:glacial acetic acid (50:13:3).
実施例 1
(1) リトコール酸0.3%、7α−ヒドロキシコラン
酸0.1%を含有するケノデオキシコール酸5.0g
をトリオクチルアミン9.01g(2倍モル量)を
含むベンゼン42mlに溶解し、この溶液中へ、撹
拌下、水酸化ナトリウム0.495g(0.97倍モル
量)を含有する水溶液50mlを7分間で滴下し
た。さらに10分間撹拌を続けたのち、30秒間静
置し、水層を分取した。分取した水溶液中へ
2.5%硫酸を滴下すると無定形固体が沈殿し、
これをろ過、水洗、乾燥して、ケノデオキシコ
ール酸4.8gを得た。Example 1 (1) 5.0 g of chenodeoxycholic acid containing 0.3% lithocholic acid and 0.1% 7α-hydroxycholanic acid
was dissolved in 42 ml of benzene containing 9.01 g (2 times the molar amount) of trioctylamine, and 50 ml of an aqueous solution containing 0.495 g (0.97 times the molar amount) of sodium hydroxide was added dropwise into this solution over 7 minutes while stirring. . After continuing stirring for an additional 10 minutes, the mixture was allowed to stand for 30 seconds, and the aqueous layer was separated. into the separated aqueous solution
When 2.5% sulfuric acid was added dropwise, an amorphous solid precipitated.
This was filtered, washed with water, and dried to obtain 4.8 g of chenodeoxycholic acid.
(2) 上記で分離されたベンゼン溶液を洗浄再生す
るために該溶液中へ、水酸化ナトリウム0.051
g含有する水溶液40mlを撹拌下に加えて10分間
撹拌を続けたのち静置し、ベンゼン溶液層を分
取した。この操作でリトコール酸及び7α−ビ
ロキシコラン酸が水層へ移行した。(2) In order to wash and regenerate the benzene solution separated above, add 0.051 ml of sodium hydroxide into the solution.
40 ml of an aqueous solution containing g was added under stirring, stirring was continued for 10 minutes, the mixture was allowed to stand, and the benzene solution layer was separated. By this operation, lithocholic acid and 7α-byroxycholanic acid were transferred to the aqueous layer.
(3) (2)で得たベンゼン溶液へ(1)で得たケノデオキ
シコール酸4.8gを溶解し、該溶液中へ水酸化
ナトリウム0.475g(0.97倍モル量)を含む水
溶液50mlを加え10分間撹拌したのち、静置し、
水層を分取した。分取した水溶液中へ2.5%硫
酸を滴下すると無定形固体が沈澱し、これをろ
取し、水洗し、乾燥してケノデオキシコール酸
4.65g(回収率93%)を得た。リトコール酸は
0.04%に減少し、7α−ヒドロキシコラン酸は検
出されなかつた。(3) Dissolve 4.8 g of chenodeoxycholic acid obtained in (1) in the benzene solution obtained in (2), add 50 ml of an aqueous solution containing 0.475 g (0.97 times the molar amount) of sodium hydroxide to the solution, and stir for 10 minutes. After that, let it stand,
The aqueous layer was separated. When 2.5% sulfuric acid was added dropwise into the separated aqueous solution, an amorphous solid precipitated, which was collected by filtration, washed with water, and dried to produce chenodeoxycholic acid.
4.65g (recovery rate 93%) was obtained. Lithocholic acid is
The concentration decreased to 0.04%, and 7α-hydroxycholanic acid was not detected.
実施例 2
(1) リトコール酸4.0%、7β−ヒドロキシコラン
酸1.0%を含有するウルソデオキシコール酸
39.2gを水酸化ナトリウム4.0g(等モル量)
を含む水溶液500mlに溶解し、この溶液中へト
リラウリルアミン156.6g(3倍モル量)を含
むトルエン溶液を600mlを加えて10分間撹拌し、
静置後、水層を分取した。Example 2 (1) Ursodeoxycholic acid containing 4.0% lithocholic acid and 1.0% 7β-hydroxycholanic acid
39.2g to 4.0g (equimolar amount) of sodium hydroxide
was dissolved in 500 ml of an aqueous solution containing trilaurylamine, 600 ml of a toluene solution containing 156.6 g (3 times the molar amount) of trilaurylamine was added to this solution, and the mixture was stirred for 10 minutes.
After standing still, the aqueous layer was separated.
(2) 上記で分離されたトルエ溶液層へ、水酸化ナ
トリウム0.8gを含む水溶液300mlを加え10分間
撹拌し、静置し、トルエン層を分取し、さらに
水300mlで洗浄してトルエン溶液を洗浄再生し
た。(2) Add 300 ml of an aqueous solution containing 0.8 g of sodium hydroxide to the toluene solution layer separated above, stir for 10 minutes, let stand, separate the toluene layer, and wash with 300 ml of water to separate the toluene solution. Washed and regenerated.
(3) (1)で分取した水層へ0.1規定硫酸50mlを加え
て液のPHを低下させたのち、さらに(2)で洗浄再
生したトルエン溶液を加えて、再度抽出操作を
行ない、水層を分取した。(3) After adding 50 ml of 0.1N sulfuric acid to the aqueous layer separated in (1) to lower the pH of the liquid, further adding the toluene solution washed and regenerated in (2) and performing the extraction operation again. The layers were separated.
(4) (3)で分離したトルエン溶液を(2)と同様の操作
によつて洗浄再生した。(4) The toluene solution separated in (3) was washed and regenerated in the same manner as in (2).
(5) (3)で分取した水層へ0.1規定硫酸50mlを加え
て液のPHを低下させたのち、さらに(4)で洗浄再
生したトルエン溶液を加えて、10分間撹拌し、
静置し、水層を分取した。分取した水溶液中へ
2.5%硫酸を滴下し、沈殿した体定形固体をろ
取し、水洗し、乾燥してウロソデオキシコール
酸34.3g(回収率87.5%)を得た。(5) After adding 50 ml of 0.1N sulfuric acid to the aqueous layer separated in (3) to lower the pH of the liquid, further adding the toluene solution washed and regenerated in (4) and stirring for 10 minutes.
The mixture was allowed to stand still, and the aqueous layer was separated. into the separated aqueous solution
2.5% sulfuric acid was added dropwise, and the precipitated solid was collected by filtration, washed with water, and dried to obtain 34.3 g of urosodeoxycholic acid (recovery rate: 87.5%).
リトコール酸は0.05%、7β−ヒドロキシコラ
ン酸は0.01%に減少した。 Lithocholic acid decreased to 0.05% and 7β-hydroxycholanic acid decreased to 0.01%.
実施例 3
(1) リトコール酸0.2%を含有する3α−ヒドロキ
シ−7−ケトコラン酸3.92gを水酸化カリウム
0.56g(等モル量)を含む水溶液80mlに溶解
し、この水溶液中へトリヘキシルアミン13.48
g(5.0倍モル量)を含むジイソブチルケトン
50mlを加えて10分間撹拌し、静置後水層を分取
した。Example 3 (1) 3.92 g of 3α-hydroxy-7-ketocholanic acid containing 0.2% lithocholic acid was added to potassium hydroxide.
Trihexylamine is dissolved in 80 ml of an aqueous solution containing 0.56 g (equimolar amount), and 13.48 g of trihexylamine is added to this aqueous solution.
diisobutyl ketone containing g (5.0 times the molar amount)
50 ml was added and stirred for 10 minutes, and after standing still, the aqueous layer was separated.
(2) 上記で分離した有機溶液中へ水酸化カリウム
0.168gを含む水溶液40mlを加えて10分間撹
拌し静置し、有機溶媒層を分取し、さらに水40
mlにて洗浄した。(2) Add potassium hydroxide to the organic solution separated above.
Add 40 ml of an aqueous solution containing 0.168 g, stir for 10 minutes, let stand, separate the organic solvent layer, and add 40 ml of water.
Washed with ml.
(3) (1)で分取した水層へ0.1規定硫酸3mlを加え
て液のPHを低下させたのち、さらに、(2)で洗浄
再生した有機溶液を加えて10分間混合撹拌し、
静置し、水層を分取した。該水溶液中へ2.5%
塩酸を滴下し、沈澱した無定形固定をろ過し、
水洗し、乾燥して3α−ビドロキシ−7−ケト
コラン酸3.67g(回収率94.1%)を得た。リト
コール酸は0.02%に減少した。(3) After adding 3 ml of 0.1N sulfuric acid to the aqueous layer separated in (1) to lower the pH of the liquid, the organic solution washed and regenerated in (2) was further added and mixed and stirred for 10 minutes.
The mixture was allowed to stand still, and the aqueous layer was separated. 2.5% into the aqueous solution
Add hydrochloric acid dropwise, filter out the precipitated amorphous fixation,
After washing with water and drying, 3.67 g of 3α-hydroxy-7-ketocholanic acid (recovery rate 94.1%) was obtained. Lithocholic acid decreased to 0.02%.
実施例 4
(1) リトコール酸0.3%、7α−ヒドロキシコラン
酸0.2%を含有するケノデオキシコール酸50g
を水酸化ナトリウム5.10g(等モル量)を含む
水溶液1に溶解し、この溶液中へメチルジラ
ウリルアミン187.3g(4倍モル量)を含むト
ルエン溶液1を加えて10分間撹拌し、静置
し、水層を分取した。Example 4 (1) 50 g of chenodeoxycholic acid containing 0.3% lithocholic acid and 0.2% 7α-hydroxycholanic acid
was dissolved in aqueous solution 1 containing 5.10 g (equimolar amount) of sodium hydroxide, and toluene solution 1 containing 187.3 g (4 times the molar amount) of methyldilaurylamine was added to this solution, stirred for 10 minutes, and allowed to stand still. Then, the aqueous layer was separated.
(2) 上記で分離したトルエン溶液層へ水酸化ナト
リウム1.02gを含む水溶液800mlを加えて5分
間撹拌し、静置し、トルエン層を分取し、さら
に水800mlで洗浄してトルエン溶液を洗浄再生
した。(2) Add 800 ml of an aqueous solution containing 1.02 g of sodium hydroxide to the toluene solution layer separated above, stir for 5 minutes, let stand, separate the toluene layer, and wash with 800 ml of water to wash the toluene solution. Replayed.
(3) (1)で分取した水層へ0.1規定硫酸38.3mlを加
えて液のPHを低下させたのち(2)で洗浄再生した
トルエン溶液を加えて再度抽出操作を行ない水
層を分取した。(3) Add 38.3ml of 0.1N sulfuric acid to the aqueous layer separated in (1) to lower the pH of the liquid, then add the toluene solution washed and regenerated in (2) and perform the extraction operation again to separate the aqueous layer. I took it.
(4) (3)で分離したトルエン溶液を(2)と同様の操作
によつて洗浄再生した。(4) The toluene solution separated in (3) was washed and regenerated in the same manner as in (2).
(5) (3)で分取した水層へ0.1規定硫酸38.3mlを加
えて液のPHを低下させたのち、さらに(4)で洗浄
再生したトルエン溶液を加えて10分間撹拌し、
静置し、水層を分取した。分取した水溶液中へ
2.5%硫酸を滴下し、沈殿した間定形固体をろ
取し、水洗し、乾燥してケノデオキシコール酸
46.9g(93.8%)を得た。(5) After adding 38.3 ml of 0.1N sulfuric acid to the aqueous layer separated in (3) to lower the pH of the liquid, further adding the toluene solution washed and regenerated in (4) and stirring for 10 minutes.
The mixture was allowed to stand still, and the aqueous layer was separated. into the separated aqueous solution
Add 2.5% sulfuric acid dropwise, filter the precipitated solid, wash with water, and dry to obtain chenodeoxycholic acid.
46.9g (93.8%) was obtained.
リトコール酸は0.04%に、7α−ヒドロキシコ
ラン酸は0.01%以下に減少した。 Lithocholic acid decreased to 0.04%, and 7α-hydroxycholanic acid decreased to less than 0.01%.
実施例 5
(1) リトコール酸0.3%、7β−ヒドロキシコラン
酸0.3%を含有するウロソデオキシコール酸100
gを水酸化カリウム14.3g(等モル量)を含有
する水溶液4に溶解し、この水溶液へN、N
−ジメチルベンジルアミン103.3ml(3倍モル
量)を含むベンゼン3を加えて10分間撹拌
し、静置し、水層を分取した。Example 5 (1) Urosodeoxycholic acid 100 containing 0.3% lithocholic acid and 0.3% 7β-hydroxycholanic acid
g was dissolved in aqueous solution 4 containing 14.3 g (equimolar amount) of potassium hydroxide, and N, N
- Benzene 3 containing 103.3 ml (3 times the molar amount) of dimethylbenzylamine was added, stirred for 10 minutes, allowed to stand, and the aqueous layer was separated.
(2) 上記で分離したベンゼン溶液中へ、水酸化カ
リウム2.86gを含む水溶液2を加えて10分間
撹拌し、静置し、ベンゼン溶液層を分取し、さ
らに水2で洗浄した。(2) Aqueous solution 2 containing 2.86 g of potassium hydroxide was added to the benzene solution separated above, stirred for 10 minutes, allowed to stand, and the benzene solution layer was separated and further washed with water 2.
(3) (1)で分取した水層へ0.1規定硫酸76.5mlを加
えて、液のPHを低下させたのち、さらに(2)で洗
浄再生したベンゼン溶液を加えて10分間混合撹
拌し、静置し、水層を分取した。該水溶液へ
2.5%硫酸を滴下し、沈殿した無定形固体をろ
取し、水洗し、乾燥してウルソデオキシコール
酸91.2g(回収率91.2%)を得た。リトコール
酸は0.06%に7β−ヒドロキシコラン酸は0.02%
に減少した。(3) Add 76.5 ml of 0.1N sulfuric acid to the aqueous layer separated in (1) to lower the pH of the liquid, then add the benzene solution washed and regenerated in (2) and mix and stir for 10 minutes. The mixture was allowed to stand still, and the aqueous layer was separated. to the aqueous solution
2.5% sulfuric acid was added dropwise, and the precipitated amorphous solid was collected by filtration, washed with water, and dried to obtain 91.2 g of ursodeoxycholic acid (recovery rate 91.2%). Lithocholic acid is 0.06% and 7β-hydroxycholanic acid is 0.02%.
decreased to
Claims (1)
ルカリ水溶液および下式で示される第3級アミン (式中R1、R2およびR3は同一または異なつて炭
素数1〜20個のアルキル基またはアラルキル基を
示す。ただし、R1、R2、R3のうち少なくとも1
つは炭素数3以上のアルキル基またはアラルキル
基を示す。) を加えて撹拌したのち、水溶液層を分取し、分取
した水溶液に酸を加えて胆汁酸を沈殿させること
を特徴とする胆汁酸の精製方法。 2 精製する胆汁酸がウルソデオキシコール酸、
ケノデオキシコール酸または3α−ヒドロキシ−
7−ケトコラン酸である特許請求の範囲第1項記
載の精製方法。 3 粗製胆汁酸中に含まれる不純物胆汁酸がリト
コール酸、コラン酸、7α−ヒドロキシコラン酸
または7β−ヒドロキシコラン酸である特許請求
の範囲第1項記載の精製方法。 4 第3級アミンがトリヘキシルアミン、トリオ
クチルアミン、トリラウリルアミン、メチルジラ
ウリルアミンまたはN、N−ジメチルベンジルア
ミンである特許請求の範囲第1項の記載の精製方
法。 5 粗製胆汁酸に水と層分離し得る有機溶剤、ア
ルカリ水溶液および第3級アミン(前記と同じ意
味を有する。)を加えて混合したのち、水溶液層
を分取した残りの有機溶媒層に再びアルカリ水溶
液を加えて混合し、水溶液層を分離除去すること
により洗浄再生された有機溶剤を再使用する特許
請求の範囲第1項記載の精製方法。[Scope of Claims] 1. Crude bile acid, an organic solvent capable of phase separation from water, an alkaline aqueous solution, and a tertiary amine represented by the following formula. (In the formula, R 1 , R 2 and R 3 are the same or different and represent an alkyl group or an aralkyl group having 1 to 20 carbon atoms. However, at least one of R 1 , R 2 and R 3
One represents an alkyl group or an aralkyl group having 3 or more carbon atoms. ) is added and stirred, the aqueous solution layer is separated, and an acid is added to the separated aqueous solution to precipitate the bile acids. 2 The bile acid to be purified is ursodeoxycholic acid,
Chenodeoxycholic acid or 3α-hydroxy-
The purification method according to claim 1, wherein the purification method is 7-ketocholanic acid. 3. The purification method according to claim 1, wherein the impurity bile acid contained in the crude bile acid is lithocholic acid, colanic acid, 7α-hydroxycholanic acid or 7β-hydroxycholanic acid. 4. The purification method according to claim 1, wherein the tertiary amine is trihexylamine, trioctylamine, trilaurylamine, methyldilaurylamine or N,N-dimethylbenzylamine. 5. Add and mix an organic solvent that can be separated into layers from water, an alkaline aqueous solution, and a tertiary amine (same meaning as above) to the crude bile acid, and then add the aqueous solution layer to the remaining organic solvent layer again. The purification method according to claim 1, wherein the organic solvent that has been washed and regenerated by adding and mixing an aqueous alkaline solution and separating and removing the aqueous solution layer is reused.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5834884A JPS60202897A (en) | 1984-03-28 | 1984-03-28 | Purification of bile acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5834884A JPS60202897A (en) | 1984-03-28 | 1984-03-28 | Purification of bile acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60202897A JPS60202897A (en) | 1985-10-14 |
| JPH0367080B2 true JPH0367080B2 (en) | 1991-10-21 |
Family
ID=13081812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5834884A Granted JPS60202897A (en) | 1984-03-28 | 1984-03-28 | Purification of bile acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60202897A (en) |
-
1984
- 1984-03-28 JP JP5834884A patent/JPS60202897A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60202897A (en) | 1985-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5508453A (en) | Intermediate for use in the preparation of taurocholanic acids | |
| JPH02292300A (en) | Fluorinated bile acid derivative, preparation thereof, and pharmaceutical composition containing same | |
| US4186143A (en) | Chenodeoxycholic acid recovery process | |
| US4379093A (en) | Process for preparing high purity ursodeoxycholic acid | |
| JPH0665286A (en) | New process for producing 11-ketosteroid derivative | |
| JP5107257B2 (en) | Method for purifying chenodeoxycholic acid | |
| EP1074558A1 (en) | Process for the preparation of mometasone furoate | |
| US3965131A (en) | Process for the purification of crude chenodeoxycholic acid | |
| JPH0364508B2 (en) | ||
| JP5107262B2 (en) | Method for purifying chenodeoxycholic acid | |
| JPS60202897A (en) | Purification of bile acid | |
| JPS58113202A (en) | Purification of bile acid | |
| US2705232A (en) | Ternorcholanylthiazoles | |
| KR100396113B1 (en) | Purification method of tauroursodeoxycholic acid | |
| JPH07116221B2 (en) | Method for producing ursodeoxycholic acid | |
| JPS606699A (en) | Purification of bile acid | |
| JP3291987B2 (en) | Purification method of O, S-dimethyl-N-acetylphosphoramidothioate | |
| JPH07267985A (en) | Method for producing tauroursodeoxycholic acid hydrate | |
| US20070037992A1 (en) | Method for the purification of crude diacerein by means of toluene | |
| US4279828A (en) | Process for separating 3-hydroxy steroids or sterols from mixtures such as lipids | |
| US2881192A (en) | Method of isolating and purifying keto steroids and new keto steroid compounds | |
| WO1999014186A1 (en) | Method of purifying and recovering sweetener | |
| CH628647A5 (en) | METHOD FOR PRODUCING 17BETA-HYDROXY-3-OXO-17ALPHA-PREGN-4-EN-21-CARBONIC ACID GAMMA LACTONE. | |
| US2897215A (en) | Method of isolating and purifying keto steroids and new keto steroid compounds | |
| JPH0753524A (en) | Production of 2-butyl-4-chloroimidazole-5-carbaldehyde |